Liste Fiyatı
:
 USD+KDV ( TL)
İzmir Tıp
:
105.00 USD+KDV (Fiyat KDV Dahil :5,035.30 TL)
1 USD
:
44,4030 TL.
Acute Coronary Syndromes : A Companion to Braunwald's Heart Disease
  • ISBN
    :
    9780721696133
  • Format
    :
    Hardcover
  • Dil
    :
    İngilizce
  • Sayfa Sayısı
    :
    768
  • Baskı Tarihi
    :
    2003
  • Baskı Sayısı
    :
    1
  • Yazar
    :
  • Yayınevi
    :
  • Teslimat Bilgisi
    :
    1-3 İş Gününde Teslim
 
One of the leading experts in the field and a stellar cast of contributors provide all of the scientific and clinical information needed to facilitate rapid evaluation and immediate management of acute coronary syndromes using today's full range of strategies?from pharmaceutical approaches to revascularization. Readers will also find coverage of special considerations for specific populations and care settings, as well as the recent guidelines from the AHA/ACC and ESC Task Forces for the management of these challenging, life-threatening syndromes. Examines the molecular mechanisms of acute coronary syndromes, inflammation and immunity. Explains the function of the endothelium and its role in atherosclerosis. Explores all of the current methods of diagnosis and provides outcomes data for each modality, encompassing ECG, biochemical markers, angiography, nuclear cardiology, echocardiography, MRI, CT, and more. Covers today's full range of available management strategies, including antiplatelet therapy, gene therapy, and pharmaceutical approaches to inflammation, revascularization, and more. Discusses special considerations for the care of acute coronary syndromes in the ED and CCU. Offers guidance on the management of special populations and chronic patients. Includes guidelines for management of acute coronary syndromes from the AHA/ACC and ESC Task Forces, with commentary from Eugene Braunwald, MD and Michel Bertrand, MD.
Foreword xiii Preface xv Section 1 Acute Coronary Syndromes and Clinical Practice 1 1 From Pre-infarction Angina to Acute Coronary Syndromes: A Historical Perspective 1 2 Acute Coronary Syndromes: National and International Dimensions of the Problem 10 3 An Epidemiological Perspective: Society, Environment, Risk Factors, and Genetics 15 4 Natural History and Prognosis 49 Section 2 Pathophysiology 67 5 Pathology of Stable and Acute Coronary Syndromes 67 6 Molecular Mechanisms of the Acute Coronary Syndromes: The Roles of Inflammation and Immunity 80 7 The Role of Infection 88 8 Triggers to Acute Coronary Syndromes 108 9 Novel Risk Factors in Acute Coronary Syndromes 119 10 What Cardiologists Need to Know on Depression in Acute Coronary Syndromes 131 Section 3 Diagnosis 145 11 Clinical Recognition of Acute Coronary Syndromes 145 12 Acute Coronary Syndromes in the Emergency Department: Diagnosis, Risk Stratification, and Management 152 13 Electrocardiography, ECG Monitoring, and Provocative Stress Testing in Acute Coronary Syndromes 168 14 Biochemical Markers of Myocardial Necrosis 187 15 Markers of a Thrombotic State 197 16 Markers of Inflammation 209 17 Coronary Angiography and the Culprit Lesion in Acute Coronary Syndromes 226 18 Echocardiography in Acute Coronary Syndromes 250 19 Nuclear Cardiology Techniques in Acute Coronary Syndromes 269 20 Computed Tomography in Coronary Artery Disease 285 21 Emerging Diagnostic Procedures for the Vulnerable Plaque 294 22 Risk Stratification in Non-ST-Segment Elevation Acute Coronary Syndromes 308 23 Continuous Risk Stratification 322 Section 4 Pharmacologic Management 331 24 Nitrates and Nitric Oxide Donors 331 25 [beta]-Blockers and Calcium Channel Blockers: Use in Acute Coronary Syndromes 341 26 ATP-Sensitive Potassium Channels, Adenosine, and Preconditioning 351 27 Metabolic Interventions 359 28 Antiplatelet Therapy 368 29 Anticoagulant Therapy 400 Section 5 Management Strategies 419 30 Acute Plaque Passivation and Endothelial Therapy 419 31 Anti-thrombotic Management 431 32 Treatment of Cardiovascular Inflammation 444 33 Myocardial Cell Protection in Acute Coronary Syndromes 453 Section 6 Revascularization 473 34 Revascularization in Acute Coronary Syndromes: Which Patients and When? 473 35 Advantages and Hazards of Early Revascularization 492 36 New Surgical and Percutaneous Revascularization Procedures 498 37 Pharmacologic Revascularization 515 38 The Patient with Disabling Angina Not Amenable to Revascularization Procedures 539 Section 7 Special Subgroups 553 39 The Elderly, Women, and Patients with Diabetes Mellitus 553 40 Coronary Artery Spasm 574 41 The Patient with Chest Pain Despite Normal Coronary Angiography 588 42 Cocaine and Other Environmental Causes of Acute Coronary Syndromes 594 Section 8 From the Acute Phase to the Chronic Phase 601 43 Control of Risk Factors 601 44 Dietary Intervention in Coronary Care Units and in Secondary Prevention 613 Section 9 Outlook to the Future 633 45 Perspective for Gene and Cell-Based Therapy 633 46 Cardiovascular Regeneration and Stem Cell Differentiation 649 47 Identifying the Vulnerable Plaque and the Vulnerable Patient 661 48 The Modern Coronary Care Unit 677 Section 10 Guidelines for Management 689 49 Guidelines of the European Society of Cardiology 689 50 ACC/AHA 2002 Guidelines Update for the Management of Patients with Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--Summary Article 709 Index 719